ClinicalTrials.govpublic full text
The Comparison of Ibandronate and Zoledronic Acid After Denosumab Discontinuation
postmenopausal osteoporosis, postmenopausal osteopenia, primary osteoporosis, osteoporosis, postmenopausal, osteopenia, denosumab, ibandronate, zoledronic acid, discontinuation, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 894778
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.